Susan Reutzel-Edens Explained

Susan Reutzel-Edens
Birth Name:Susan Marie Reutzel
Workplaces:Eli Lilly and Company
Cambridge Crystallographic Data Centre
Alma Mater:University of Minnesota
Thesis Title:Hydrogen-bonded imide aggregates : solid-state design, preparation, and characterization by solid-state NMR
Thesis Url:http://www.worldcat.org/oclc/29053127
Thesis Year:1991

Susan Reutzel-Edens is an American chemist who is the Head of Science at the Cambridge Crystallographic Data Centre. Her work considers solid state chemistry and pharmaceuticals. She is interested in crystal structure predictions. She serves on the editorial boards of CrystEngComm and Crystal Growth & Design.

Early life and education

Reutzel-Edens was a doctoral researcher at the University of Minnesota, where she studied the design and characterization of hydrogen-bonded imide aggregates. She worked in the laboratory of crystallographer Margaret C. Etter, and made use of solid state NMR.[1] During her doctorate, she investigated how hydrogen bonds could be used as design elements that guided the solid-state self assembly of organic molecules. She made use of the Cambridge Structural Database to unravel the complicated relationships between hydrate formation and crystal polymorphism.

Research and career

Reutzel-Edens joined Eli Lilly and Company, where she recognized that it would be challenging to identify and design increasingly complicated drug targets, and instead proposed the use of computation approaches. Through collaborations with the Cambridge Crystallographic Database, Reutzel-Edens founded the Lilly solid form design program.[2] Her research has considered crystal polymorphism and the crystal nucleation. She used computational approaches to identify commercially viable small molecule drug products.[3] [4] [5] To this end, Reutzel-Edens proposed the use of crystal structure prediction to identify pharmaceutical molecules to complement experimental investigations.[6] She has described Olanzapine as “an incredible molecule, a gift to crystal chemistry that keeps on giving,”.[7]

In 2018, Reutzel-Edens was appointed Fellow of the Royal Society of Chemistry. She serves on the editorial boards of CrystEngComm and Crystal Growth and Design.[8] In 2021 Reutzel-Edens joined the Cambridge Crystallographic Database as Head of Science.[9]

Notes and References

  1. Hydrogen-bonded imide aggregates: solid-state design, preparation, and characterization by solid-state NMR . 1991 . English . Susan Marie . Reutzel. 29053127 .
  2. Reutzel-Edens . Susan M. . 2022-01-18 . Computer-aided solid form design . CrystEngComm . en . 24 . 3 . 431–433 . 10.1039/D1CE90150H . 1466-8033. free .
  3. Web site: Q&A with the new CCDC Head of Science - The Cambridge Crystallographic Data Centre (CCDC) . 2022-06-21 . www.ccdc.cam.ac.uk . en.
  4. Web site: Crystal Growth & Design Webinar Series: Inspiring Medicines Design through Solid-State Chemistry . 2022-06-21 . connect.acspubs.org.
  5. Price . Sarah L. . Reutzel-Edens . Susan M. . 2016-06-01 . The potential of computed crystal energy landscapes to aid solid-form development . Drug Discovery Today . en . 21 . 6 . 912–923 . 10.1016/j.drudis.2016.01.014 . 26851154 . 1359-6446.
  6. Price . Sarah L. . Braun . Doris E. . Reutzel-Edens . Susan M. . 2016 . ChemInform Abstract: Can Computed Crystal Energy Landscapes Help Understand Pharmaceutical Solids? . ChemInform . 47 . 29 . 10.1002/chin.201629287 . 0931-7597.
  7. Reutzel-Edens . S. M. . Bhardwaj . R. M. . 2020-11-01 . Crystal forms in pharmaceutical applications: olanzapine, a gift to crystal chemistry that keeps on giving . IUCrJ . en . 7 . 6 . 955–964 . 10.1107/S2052252520012683 . 33209310 . 7642794 . 2052-2525.
  8. Web site: Introducing our new Editorial Board Member: Susan Reutzel-Edens – CrystEngComm Blog . 2022-06-21 . en-US.
  9. Web site: Public Profile - The Cambridge Crystallographic Data Centre (CCDC) . 2022-06-21 . www.ccdc.cam.ac.uk . en.